RIGOBERTO RAMOS: Open Payments
NPI 1548833411 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$85 in 4 payments from 4 companies in 2025. Trend: 2023 $62 · 2024 $108 · 2025 $85
Food & beverage: $85
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Genentech USA, Inc. | 1 | $14 |
Products named: BLENREP, Vanflyta, SCEMBLIX, Venclexta.
Industry payments across CA — which companies pay providers there.
